JNJ

174.13

+0.25%↑

ABBV

198.84

-0.12%↓

AZN

74.32

+0.36%↑

NVS

118.56

+0.28%↑

ABT

130.85

-2.14%↓

JNJ

174.13

+0.25%↑

ABBV

198.84

-0.12%↓

AZN

74.32

+0.36%↑

NVS

118.56

+0.28%↑

ABT

130.85

-2.14%↓

JNJ

174.13

+0.25%↑

ABBV

198.84

-0.12%↓

AZN

74.32

+0.36%↑

NVS

118.56

+0.28%↑

ABT

130.85

-2.14%↓

JNJ

174.13

+0.25%↑

ABBV

198.84

-0.12%↓

AZN

74.32

+0.36%↑

NVS

118.56

+0.28%↑

ABT

130.85

-2.14%↓

JNJ

174.13

+0.25%↑

ABBV

198.84

-0.12%↓

AZN

74.32

+0.36%↑

NVS

118.56

+0.28%↑

ABT

130.85

-2.14%↓

Search

Stryker Corp

Fermé

SecteurSoins de santé

376.55 -0.6

Résumé

Variation du prix de l'action

24h

Actuel

Min

375.2

Max

378.59

Chiffres clés

By Trading Economics

Revenu

884M

1.5B

Ventes

156M

6B

P/E

Moyenne du Secteur

49.999

34.393

BPA

3.13

Rendement du dividende

0.88

Marge bénéficiaire

25.54

Employés

53,000

EBITDA

179M

1B

Recommandations

By TipRanks

Recommandations

Achat Fort

Prévisions sur 12 Mois

+15% upside

Dividendes

By Dow Jones

Rendement du dividende

Moyenne du Secteur

0.88%

2.54%

Prochains Résultats

28 oct. 2025

Date du Prochain Dividende

31 oct. 2025

Date du Prochain Détachement de Dividende

30 sept. 2025

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

-7.3B

146B

Ouverture précédente

377.15

Clôture précédente

376.55

Sentiment de l'Actualité

By Acuity

40%

60%

131 / 374 Classement par Healthcare

Score Technique

By Trading Central

Confiance

Weak Bullish Evidence

Stryker Corp Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

31 juil. 2025, 20:42 UTC

Résultats

Stryker Lifts Guidance on Improving Tariff Outlook

1 mai 2025, 20:56 UTC

Résultats

Stryker Lowers Adjusted EPS View on $200 Million Tariff Impact

28 janv. 2025, 21:55 UTC

Résultats

Stryker Sees Further Organic Sales Growth in 2025

28 janv. 2025, 21:46 UTC

Acquisitions, Fusions, Rachats

Stryker to Sell Spinal Implants Business to Viscogliosi Brothers

31 juil. 2025, 20:09 UTC

Résultats

Stryker Estimates Net Impact From Tariffs in 2025 of Approximately $175M

31 juil. 2025, 20:09 UTC

Résultats

Stryker Sales >SYK

31 juil. 2025, 20:09 UTC

Résultats

Stryker Sees FY25 Organic Net Sales Up 9.5%-10%

31 juil. 2025, 20:05 UTC

Résultats

Stryker 2Q Sales $6B >SYK

31 juil. 2025, 20:05 UTC

Résultats

Stryker 2Q Net $884M >SYK

31 juil. 2025, 20:05 UTC

Résultats

Stryker Sees FY Adj EPS $13.40-Adj EPS $13.60 >SYK

31 juil. 2025, 20:05 UTC

Résultats

Stryker 2Q EPS $2.29 >SYK

31 juil. 2025, 20:05 UTC

Résultats

Stryker 2Q Adj EPS $3.13 >SYK

31 juil. 2025, 20:05 UTC

Résultats

Stryker 2Q Sales $6B >SYK

31 juil. 2025, 20:05 UTC

Résultats

Stryker 2Q EPS $2.29 >SYK

31 juil. 2025, 20:05 UTC

Résultats

Stryker 2Q EPS $2.29 >SYK

1 mai 2025, 20:41 UTC

Résultats

Stryker Lowers Adjusted EPS View on $200M Tariff Impact

1 mai 2025, 20:11 UTC

Résultats

Stryker Cuts FY25 View To Adj EPS $13.20-Adj EPS $13.45 >SYK

1 mai 2025, 20:10 UTC

Résultats

Stryker Raising FY25 Organic Net Sales Growth Guidance Range to 8.5% to 9.5% >SYK

1 mai 2025, 20:05 UTC

Résultats

Stryker 1Q Adj EPS $2.84 >SYK

1 mai 2025, 20:05 UTC

Résultats

Stryker 1Q Net $654M >SYK

1 mai 2025, 20:05 UTC

Résultats

Stryker 1Q EPS $1.69 >SYK

1 mai 2025, 20:05 UTC

Résultats

Stryker 1Q Sales $5.87B >SYK

1 mai 2025, 20:05 UTC

Résultats

Stryker 1Q EPS $1.69 >SYK

19 févr. 2025, 13:53 UTC

Acquisitions, Fusions, Rachats

Stryker Files 8K - Asset Acquisition Or Disposition >SYK

19 févr. 2025, 13:30 UTC

Acquisitions, Fusions, Rachats

Stryker Completes Acquisition Of Inari Medical, Inc., Providing Entry Into The High-growth Peripheral Vascular Segment >SYK

28 janv. 2025, 21:09 UTC

Acquisitions, Fusions, Rachats

Stryker: Transaction Is Expected to Close in the U.S. in 1H 2025 >SYK

28 janv. 2025, 21:09 UTC

Acquisitions, Fusions, Rachats

Stryker: Agreement Includes Binding Offer to Acquire Stryker's Spinal Implants Business in France >SYK

28 janv. 2025, 21:08 UTC

Acquisitions, Fusions, Rachats

Stryker: After Closing, VB Spine Will Become a Strategic Partner to Stryker With Exclusive Access to Mako Spine and Copilot for Use With VB Spine's Implants in Spine Procedures >SYK

28 janv. 2025, 21:08 UTC

Acquisitions, Fusions, Rachats

Stryker: Agreement to Sell U.S. Spinal Implants Business to Viscogliosi Brothers, LLC to Create Newly Formed Co Called VB Spine, LLC >SYK

28 janv. 2025, 21:06 UTC

Résultats

Stryker Sees Organic Net Sales Growth of 8% to 9% for 2025 >SYK

Comparaison

Variation de prix

Stryker Corp prévision

Objectif de Prix

By TipRanks

15% hausse

Prévisions sur 12 Mois

Moyen 434.21 USD  15%

Haut 456 USD

Bas 407 USD

Basé sur 17 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Achat Fort

17 ratings

13

Achat

4

Maintien

0

Vente

Score Technique

By Trading Central

373.92 / 383.99Support & Résistance

Court Terme

Weak Bullish Evidence

Moyen Terme

Bullish Evidence

Long Terme

Bullish Evidence

Sentiment

By Acuity

131 / 374Classement par Soins de santé

Sentiment de l'Actualité

Indications Haussières

Volatilité

Inférieur à la moyenne

Changement du Volume d'Actualités (RCV)

Inférieur à la moyenne

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos Stryker Corp

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical and thoracolumbar systems that include fixation, minimally invasive and interbody systems used in spinal injury, complex spine and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment, and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, clinical communication and workflow solutions, and other medical device products that are used in various medical specialties, as well as patient and caregiver safety technologies. This segment also provides neurosurgical, neurovascular and craniomaxillofacial implant products, which include products used for minimally invasive endovascular procedures; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke; and craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Portage, Michigan.